Bala Cynwyd, Pennsylvania--(Newsfile Corp. - July 7, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ - CORZ) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to CoreWeave (NASDAQ - CRWV). Under the terms of the transaction, Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock based on a fixed exchange ratio. As of July 3, 2025, the agreed-upon exchange ratio implies a total equity value of approximately $9.0 billion.

The investigation concerns whether the Core Scientific Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257949

COMTEX_467063006/2523/2025-07-07T11:30:28